Skip to content

Global19/nextclade

 
 

Repository files navigation

Nextclade

Viral genome clade assignment, mutation calling, and sequence quality checks

by Nextstrain team

🌎 clades.nextstrain.org

Animated screenshot of the application, showcasing the user interface on main page

License package.json version

Travis CI production Travis CI staging Travis CI master Security Headers Mozilla Observatory

GitHub last commit GitHub commit activity GitHub contributors DeepScan grade


Download button

Report issue button Request feature button Discuss button


📦 Packages

This repository consists of a set of packages presented in the table below. Refer to README files of individual packages for more details.

Package Type Get Docker images
nextclade_web Web App 🌎 clades.nextstrain.org
nextclade_cli Node.js CLI 📦 @nextstrain/nextclade 🐋 nextstrain/nextclade
nextalign C++ library
nextalign_cli C++ executable 📥 Github Releases 🐋 nextstrain/nextalign

✨ Team

Nextclade is a part of Nextstrain logo Nextstrain project .

It is maintained by:

Ivan Aksamentov

Senior Software Engineer
NeherLab, Biozentrum, University of Basel

Richard Neher

Principal Investigator
NeherLab, Biozentrum, University of Basel

We are thankful to all our contributors, no matter how they contribute: in ideas, science, code, documentation or otherwise. Thanks goes to these people (emoji key):


Emma Hodcroft

🤔 ⚠️ 📢 👀

Thomas Sibley

🚇 🛡️

Theo Sanderson

💻

Natalie Stroud

🖋 🌍

Alex Rubinsteyn

📖

Christopher Bottoms

📖

Finlay Maguire

📖

This project follows the all-contributors specification. Contributions of any kind welcome!

🏢 Sponsors

We are thankful to the following companies who supported us:

Vercel logo Vercel for sponsoring Nextclade builds on their platform

⚖️ License

MIT License

About

Assign SARS-CoV-2 clades in the browser

Resources

License

Code of conduct

Stars

Watchers

Forks

Packages

No packages published

Languages

  • TypeScript 56.7%
  • C++ 17.8%
  • Python 12.5%
  • Shell 4.9%
  • JavaScript 2.7%
  • CMake 2.1%
  • Other 3.3%